Delivery Order SPE2DR25D2206-SPE2DR26F9AV5
- Not listed
- This is a $1,500 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024. The contract is for the delivery of 50mg/25ml doxorubicin liposome, a specialty medication, with a performance period ending January 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This delivery order, valued at $13,615.98, was awarded on November 4, 2025, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a non-competitive, firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense responsible for providing logistics support to military operations and healthcare systems. The place of performance is located in Conshohocken, PA,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,938.00 by the Defense Logistics Agency (DLA) on October 27, 2025, with an ultimate completion date of October 28, 2025. The delivery order is for AmBisome 50 mg vials, a specialty pharmaceutical product. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,060.31 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 24, 2025, valued at $1,348.98 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as a non-competitive award, has a completion date of September 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,307.44 to AmerisourceBergen Drug Corp on October 27, 2025, under the Pharmaceutical Pharmacovigilance Division's indefinite delivery contract. This firm fixed price delivery order, which is expected to be completed by October 28, 2025, represents a child order issued against AmerisourceBergen's larger prime indefinite delivery vehicle. The award was competitively awarded with no set-aside designation and will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,721.12 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, carries an ultimate completion date of November 5, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9AV5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Doxorubicin Liposome 20mg/10ml in 10ml vials, with a contract ceiling value of $1,922.10 and an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. As a prime vendor under the DLA Troop Support Medical contract vehicle, the company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Doxorubicin Liposome, a chemotherapy medication, exemplifies the company's role in fulfilling specialized oncology pharmaceutical requirements for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/7/25 |